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ABSTRACT 
Objectives 
• To determine the prevalence of macrosomic babies delivered at Coronation 
(now Rahima Moosa) Hospital. 
• To compare the maternal and neonatal outcome of vaginally born 
macrosomic babies versus vaginally born babies less than 4000g. 
• To determine the impact that mode of delivery of the macrosomic babies 
had on maternal and neonatal outcome. 
• To compare clinical variables for macrosomia with those published in the 
literature, in view of identifying predictive factors. 
 
Method 
Retrospective record review of all women who delivered at Coronation (Rahima 
Moosa) Hospital from 1 January 2005- 30 June 2005. 
 
Results 
A total of 134 macrosomic infants were identified, of which 76 were delivered 
vaginally, 14 by elective caesarean section and 44 by emergency caesarean 
section. During the study period, there were 5800 deliveries. The incidence of 
macrosomia in the study population was 2.3%. Characteristics specific to the 
iv 
 
cohort of macrosomic infants revealed that male sex was more common (52/74 
(70%)  in the macrosomic group vs. 32/74 (43%) in the non-macrosomic group, 
p<0.0009), length of labour was increased (13.7 vs. 10.9 hours, p=0.032), as was 
use of augmentation (16 vs. 5, p=0.009), perineal trauma (34 vs.19, p=0.010) post 
partum haemorrhage (10 vs.2, p=0.016) and shoulder dystocia (5 vs. 0, p=0.03). 
Vaginal delivery, compared to elective or emergency caesarean section resulted in 
less fetal distress (1 vs. 13, p<0.0001) and puerperal fever (4 vs. 19, p=0.0001). 
Differences in other fetal and maternal outcomes were not significant. 
 
Conclusion 
Fetal macrosomia was more likely to be associated with advanced gestational 
age, male sex, prolonged labour, post partum haemorrhage, use of augmentation, 
increased perineal trauma especially episiotomy and shoulder dystocia . 
 
Expectant management, progressing labour according to a standardized 
partogram and no elective caesarean section on the basis of clinical and or 
ultrasound diagnosis of  an increased estimated fetal weight,  appears to be the 
best form of management for the suspected macrosomic. 
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BIG BABIES, BIG PROBLEMS? 
FETAL MACROSOMIA: 
Clinical variables and maternal and perinatal outcome associated with mode 
of delivery. 
1 BACKGROUND 
As birth weight increases, the likelihood of labour abnormalities, including shoulder 
dystocia, birth trauma and permanent injury to the neonate, increases. Adverse 
maternal outcomes also increase, for example post-partum haemorrhage, perineal 
trauma and obstructed labour, as does the use of augmentation.1, 2 Fetal 
macrosomia can result in other serious complications such as perinatal asphyxia, 
meconium aspiration, labour disorders and high incidence of caesarean section. 
Antenatal diagnosis of macrosomia could possibly decrease perinatal morbidity,3 
although prenatal recognition of overgrown fetuses is often difficult because less 
than 40% are born to patients with identifiable risk factors.1, 2 The optimal mode of 
delivery and labour management of these patients is debateable and largely 
uncertain. 
 
This study was performed to gain a South African perspective on macrosomia. 
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2 INTRODUCTION 
The concept of fetal macrosomia and its adverse outcomes has been recognised 
in medicine and literary reports throughout the ages. The 16th century monk and 
physician, Francois Rabelais, told the story of the birth of Gargantua, a ‘giant’ 
baby. Several years later, Gargantua’s wife died giving birth to Pantagruel, “for he 
was so amazingly large and so heavy that he could not come into the world 
without suffocating his mother”.4 In 1891 Ortega reported the birth of a 24-pound, 
13-ounce male infant and Belcher, in 1916, claimed to have delivered the largest 
infant, a 25-pound stillborn.4 
 
Fetal growth is exponential and during the last 20 weeks of gestation the fetus 
gains 95% of its weight. Genetic, nutritional, environmental, uteroplacental, and 
fetal factors have been suggested to influence fetal growth. Uteroplacental and 
umbilical blood flow and transplacental glucose and fetal insulin are major 
determinants of fetal growth. The role of the fetal pituitary (growth hormone) and 
thyroid gland in fetal growth is not well understood; human anencephalic or 
athyroid fetuses usually have no or only minor retardation of growth. Also, it is not 
clear whether placental lactogen or somatomedin or a somatostatin-like substance 
of the placenta and fetus influences fetal growth. From experiments on rats it may 
be assumed that a specific placental-fetal growth-promoting and growth-regulating 
factor(s) exists. Identification of such a placental-fetal growth factor(s) in humans 
might aid in the prevention, diagnosis, and treatment of fetal growth retardation. 5 
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While investigating growth factors and regulation of fetal growth, Hill et al 
discovered that fetal growth demands a coordinated increase in size of the fetus 
and the placenta, both of which are determined, in part, by locally produced 
peptide growth factors. The availability of growth factors to individual tissues may 
be due to local changes in gene expression, but it is also controlled by proteolytic 
release from extracellular matrix stores. Members of the fibroblast growth factor 
(FGF) family are stored within basement membranes, while insulin-like growth 
factors (IGFs) are stored in association with specific binding proteins (IGFBPs). 
Insulin is a major trophic hormone in utero, and pancreatic beta-cell mass is 
determined by locally produced IGF-II and members of the FGF family. The 
mitogenic effects of IGF-II on beta-cells are determined by IGFBPs, which are 
themselves expressed with a distinct ontogeny within the islets of Langerhans. 
FGF-2 is also widely expressed within fetal tissues and may be an important 
regulator of placental angiogenesis. FGF-2 appears in the maternal circulation 
during pregnancy, with peak values late in the 2nd trimester. It is associated with a 
circulating binding protein derived from the extracellular domain of the FGFR1 
receptor. Levels of FGF-2 in maternal serum correlate positively with fetal size, 
both in the 2nd trimester and at term. The expression of FGF-2 in placenta and its 
presence in maternal blood are elevated in pregnancies complicated by diabetes 
and are greatest in diabetic pregnancies associated with retinopathy. Maternal 
FGF-2 may thus be a useful indicator of both fetal development and the risk of 
maternal pathology in pregnancies complicated by diabetes.6  
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Insulin is the only fetal hormone related to intrauterine growth. Maternal insulin 
cannot diffuse through the placental membrane and therefore insulin is derived 
from the fetus. Clinical and experimental evidence has indicated that insulin can 
be considered the true fetal growth hormone. There is a positive correlation 
between plasma insulin levels and fetal weight in a significant number of animal 
species. High levels of insulin infusion resulted in a 10-25% rate of change in 
weight  in monkeys and rats. Intrauterine growth retardation had been reported in 
full term neonates with pancreatic agenesis. Insulin has a significant role in 
postnatal life as an anabolic hormone, mainly in carbohydrate metabolism. In fetal 
growth, insulin is the most recognized regulatory hormone. The fetal pancreas is 
the only source of insulin in the fetal circulation and is already present at 8-10 
weeks gestation. It remains relatively inactive until 20 weeks of gestation, when 
the insulin response to glucose becomes evident. The insulin response to 
exogenous glucose is related to the endogenous glucose levels in fetal circulation, 
which mandate the sensitivity of the fetal beta cells. Thus chronic fetal 
hyperglycemia accelerates the development of insulin secretory mechanisms 
predisposing infants of mothers with diabetes to have a mature insulin response.4. 
 
The role of thyroid hormone and growth hormone in postnatal growth is well 
established, but these hormones appear to have a minimal role in  prenatal 
growth. Adrenal corticosteroids fulfil a critical role in the induction of  maturational 
processes in specific organ systems such as the lung and intestine. The influence 
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of growth hormone on regulation of fetal growth is negligible. This may be related 
to the absence of growth hormone receptors in the fetal liver. 4. 
 
In fetal macrosomia, the fetal growth pattern and type of tissue overgrowth reflects 
the underlying aetiology. Insulin-sensitive tissues, such as the heart, liver and 
spleen, thymus, adrenal gland, subcutaneous fat, and shoulder girdle, can show 
differential glycogen and fat deposition when insulin levels are high. As a result, 
total body fat, shoulder and upper-extremity circumference, upper-extremity skin-
fold thickness, and liver size are disproportionately greater in macrosomic infants 
of diabetic women compared with those of women without diabetes. 7,8  These 
differences in growth patterns are at least partially responsible for the significant 
associated fetal, neonatal, and maternal risks. 9 
 
Macrosomia is arbitrarily defined as having a fetal weight of above the 90th 
percentile for the expected gestation, a birth weight of above 4000g or 4500g or a 
birth weight of over +2 standard deviation of the mean birth weight by gestational 
age.10 Fetal macrosomia may be defined using a relative or absolute scale,1 but 
when arbitrarily defined, it is a birth weight of more than 4000g. Fetal macrosomia 
complicates more than 10% of all pregnancies in the United States 11 and is 
associated with increased risks of caesarean section,12 induction of labour, 
operative delivery, obstructed labour and trauma to the birth canal and the fetus.13  
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The prevalence varies substantially across different continents, namely <3% in 
Nigeria, Pakistan, Thailand, and Taiwan but ≥ 20% in Denmark and the Republic 
of Croatia.14 A study by Essel et al, which had an African perspective to it, 
examining the incidence of macrosomia in the black African population attending 
Umtata General Hospital, reported an incidence of 3.43% of all singleton 
deliveries.15 Buchmann in his study of the population in the Chiawelo district of 
Soweto, calculated the incidence of fetal macrosomia to be 2.3%.16 
 
As was noted previously, triggers for fetal growth appear to be both genetic and 
environmental. 17 When evaluating risk factors for macrosomia or excessive fetal 
growth, Wallace et al found the initial drive to be genetic with male genotype and 
Caucasian ethnicity being risk factors for increased fetal size  17, but they like 
many others also found that environmental risk factors also play a role. These 
include a negative smoking history, gestation >40 weeks and the presence of 
maternal diabetes (both pre-pregnancy and gestational). 17 
 
A number of other risk factors for fetal macrosomia are widely recognized, 
including increased age, maternal pre-pregnancy weight, maternal impaired 
glucose intolerance, multiparity, previous macrosomic infant, excessive weight 
gain during pregnancy, parental stature (height) 13 and high maternal birth weight1, 
12,30  The strongest risk factor is maternal diabetes which results in a twofold 
increase in the incidence of macrosomia.  Clausen et al in their study of maternal 
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anthropometric and metabolic factors in the first half of pregnancy and risk of 
neonatal macrosomia in term pregnancies also found that among other factors first 
trimester BMI, gestational weight gain and placental weight were associated with 
macrosomia.  High serum insulin levels, high levels of the non-high density 
lipoprotein (HDL) cholesterol and low serum HDL cholesterol were associated with 
an increased risk of macrosomia independent of BMI, weight gain, placental 
weight and gestational diabetes. Interestingly they found that slim women with 
macrosomic infants had higher insulin compared with those with normal weight 
infants. The same did not hold true among obese women. Studies using leptin 
levels found no positive associations with macrosomia. 18 
 
The incidence of macrosomia is on the rise, and many are speculating as to the 
cause of this increased prevalence of macrosomia in certain countries over the 
last decade. Most ascribe this to the alarming increase in obesity as well as type 2 
diabetes in affluent countries.19 Fraser in his article  outlines the influence of 
maternal obesity on fetal growth.  He suggests that the excess substrate provision 
across the placenta due to an increase in fasting plasma glucose levels associated 
with maternal obesity have a direct effect on fetal growth.19 In their unit, Fraser et 
al, cultured trophoblast cells for term placentas of women with diabetes and 
showed a direct correlation in the uptake of both amino acids and glucose with 
increasing birth weight. These studies suggested that when the feto-placental unit 
is confronted by an excess availability of maternal substrates, placental transport 
mechanisms for these substrates are upregulated. There is no evidence to show 
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that the fetus can protect itself from the negative effect of this excess glucose and 
amino acid transfer across the placenta. 20 Most literature suggests a strong 
relationship between maternal obesity and fetal macrosomia. 21  
 
The Pedersen hypothesis explains how maternal diabetes stimulates fetal 
growth.17 Maternal hyperglycaemia leads to an elevation in fetal glucose levels, 
which in turn causes overstimulation of the fetal pancreas and fetal 
hyperinsulinaemia. Insulin has many growth promoting properties and the resulting 
fetal hyperinsulinaemia therefore stimulates increased fetal growth. This is 
particularly apparent in the third trimester.17 
 
It is evident that many of these risk factors (e.g. prolonged gestation, obesity and 
multiparity) are highly prevalent among pregnant women; this may therefore limit 
their utility, as even when two or more of these risk factors are present, the risk of 
fetal macrosomia is only 32%. Therefore, 34% of macrosomic infants are born to 
mothers without any risk factors and 38% of pregnant women have at least one 
risk factor.12  Excessive birth weight is associated with higher maternal pregnancy 
weight gain as well as maternal obesity, both of which have increased over the 
past two decades.1,6,14 
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In the United States approximately 10% of infants have a birth weight of 4000g or 
more and 1.5% weigh at least 4500g, with over 12% of women gaining 46lb 
(20.9kg) or more during their pregnancy in 2000 versus 9.1% a decade earlier.11 In 
a large cohort of >146 000 privately insured patients in the US, macrosomia was 
more common in this population than in the general US population, and within the 
cohort, advanced gestational age, white race and maternal age 30-39 were 
significant risk factors for macrosomia.11 Women delivering macrosomic infants 
had an increased number of adverse outcomes,22 including increased caesarean 
birth, shoulder dystocia, chorioamnionitis and post partum haemorrhage.11-13 
Vaginal delivery of a macrosomic infant has also been found to increase the risk of 
third and fourth degree lacerations fivefold.12  
 
The most feared and problematic outcome of macrosomia is shoulder dystocia,23 
where up to one fourth of infants with shoulder dystocia experience brachial plexus 
or facial nerve injuries or fractures of the humerus or clavicle.12 However, 
regardless of birth weight, most infants born after deliveries complicated by 
shoulder dystocia do not have brachial plexus injury.4 Birth asphyxia, albeit rare, is 
also a feared complication that may occur secondary to shoulder dystocia.12 
 
There are other neonatal morbidities associated with macrosomia including 
neonatal hypoglycaemia, other neonatal metabolic abnormalities and an increased 
lifetime risk of developing diabetes, hypertension, and cardiovascular disease.1  
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Barker’s hypothesis, named after David J Barker, a researcher at the University of 
Southhampton, states that reduced fetal growth is strongly associated with a 
number of chronic conditions later in life. 24 This increased susceptibility results 
from adaptations made by the fetus in an environment that was limited in 
nutritional supply. Chronic conditions that can occur as a result include coronary 
heart disease, stroke, diabetes and hypertension.24 
 
 When analysed in relation to maternal obesity and diabetes, Fraser et al imply a 
similar concept to this hypothesis where they show that the fetal hypertrophy 
associated with maternal obesity is a trigger for obesity in childhood and probably 
in adult life also.20. Many other studies echo these sentiments where an 
association with fetal macrosomia and long term health problems, including an 
increased risk of obesity in adolescence and diabetes in later life and an increased 
rate of certain childhood cancers have been reported. 17,19. 
 
Fetal macrosomia is however, extremely difficult to predict antenatally with 3 
possible major strategies being used to estimate foetal weight and therefore foetal 
macrosomia, namely: clinical risk factors, clinical estimation and 
ultrasonography.3,12,25.  
 
The American College of Obstetricians and Gynaecologists (ACOG) 26 in their 
guidelines acknowledge the difficulty of estimating fetal weight and recommend 
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Leopold’s maneuvers and measurement of the height of the uterine fundus above 
the maternal symphysis pubis as the two primary methods used for clinical 
estimation of fetal weight.26 Nahum et al in their study drew similar conclusions 
regarding the using of Leopold’s maneuvers in predicting fetal weight. 27. They 
compared results obtained from medical students and house staff physicians 
estimating fetal weight at term using this technique. Their findings were that house 
staff physicians performed significantly better than medical students and were able 
to predict fetal weight within 10% of the actual birth weight in 71% of cases vs. 
38% in the medical students group. This was presumably due to their increased 
experience in using these tactile techniques. In their study the mean birth weight 
was 3.445kg +- 458g and the range was 2.485-4.790kg.27.  
 
Clinical and ultrasonographic estimates of fetal weight are prone to error.12 Several 
studies which analysed antenatal detection of macrosomia have focused on the 
accuracy of ultrasonic estimation of fetal weight using various formulas.23 Shepard 
et al in the early 1980’s developed and revised a formula that they used to 
successfully predict fetal weight within 10% of the actual fetal weight. The formula 
is as follows Log 10 (birth weight ) = -1.7492 + 0.166/(BPD) + 0.046(AC)-2.646 
(ACxBPD) / 1.000.28 Nahum et al suggested that using a new and rather complex 
combination algorithm in sophisticated bioinformatics-processing systems, fetal 
macrosomia could be accurately predicted before delivery. An example of this 
equation is ‘birth weight= -1627+(13.18x fetal AC [mm])+(16.23xUS to delivery 
interval[days])+(0.00009964x gestational age[days] x maternal height[cm] x 26 wk 
 12 
 
maternal weight [kg]) +(3.173x gestational age[days] x maternal weight gain 
rate[kg/day] x [parity +1])2,29 This is in contrast to many studies which have failed 
to identify an accurate method of estimating fetal weight, especially by means of 
ultrasound alone30 and suggest that clinical estimation of fetal weight still plays a 
vital role in modern day medicine 23,31 and that ultrasound estimation is often too 
heavily relied upon.23 
 
 
Chauhan et al looked at the limitations of clinical and sonographic estimates of 
birth weight comparing pregnancies throughout the third trimester and they found 
that sonographically estimated fetal weight was only more accurate than clinical 
estimations in preterm and not in term or post term pregnancies. This study was 
limited to fetal weights >500g and <4500g.32 In a study on estimate of birth weight 
in term parturients, clinical estimation had significantly  higher accuracy than those 
derived sonographically. (58% vs. 32% within 10% of actual birth weight) 33. 
 
Accurate weight estimation in fetal macrosomia appears to be much more limited 
and unsuccessful. When Hart et al tried to determine which formula best predicts 
fetal weights above 4000g, their results confirmed earlier reports that weight 
prediction in fetal macrosomia tended to be inaccurate.34. They concluded that few 
of the commonly applied formulas could reliably predict birth weight and suggested 
that new methods of estimating fetal weight  in fetuses weighing >4000g are 
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required, where three dimensional volumetry may be an option. 34. Schild et al 
evaluated the accuracy of three dimensional ultrasound in fetal weight estimation 
and they confirmed the superior role of 3D ultrasound in estimating fetal weight 
close to delivery with much smaller margins of error, i.e. mean error of 25.8g+-
194.4 vs. 107.8g+-272.7 using Hansmanns‘ formula.35. Hansmanns formula is 
estimated fetal weight =-0.001665958 x abdominal transverse diameter3 in 
centrimetres (ATD)+ 0.4133629 x ATD2 – 0.5580294 x ATD – 0.01231535 x 
biparietal diameter 3 in centimetres(BPD) + 3.702 x BPD2-330.1811 x BPD –
0.4037199 x GA3 + 55.958061 x GA2 – 2,034.3901 x GA x 32,768.19.36 The use 
of 3D estimation at the extremes of fetal weight still needs evaluation.35 Hackmon 
et al evaluated a combined analysis of amniotic fluid index( AFI) and estimated 
fetal weight (EFW) in the mid third trimester and found an AFI>= 60th percentile 
and an EFW >=71st percentile during the mid third trimester are useful predictors 
of severe macrosomia at birth.37 Hackmon et al in another innovative study 
questioned whether severe macrosomia could be determined at the time of nuchal 
translucency screening. Although it was a small study group of only 20 term 
macrosomic newborns being compared to 67 appropriate for gestational age 
newborn controls, they found that fetal biometry at the time of the nuchal 
translucency screening was statistically higher in the macrosomic newborns when 
compared to controls(2.65 +-2.06 days vs. 0.68 +-1.4 days, p=0.001). 38 More 
studies are necessary, but findings from this small study suggest that some cases 
of fetal macrosomia express themselves as early as 11-14 weeks gestation.38  
 
 14 
 
The American College of Obstetricians and Gynecologists introduced a third, 
poorly investigated method to identify a macrosomic fetus. This involves asking a 
parous patient, based on their experience from a previous pregnancy to 
approximate the weight of their term fetus 3,9,17 Based on this hypothesis, Jolly et 
al (2003)  concluded that in the multigravidae, the maternal estimate of fetal weight 
may be as accurate as ultrasound prediction.13    
 
Chauhan et al also found that maternal estimates of birth weight were more 
accurate than clinical estimates of ultrasound, namely almost 70% of estimates 
were within 10% of the actual birth weight compared to 66% for clinical estimates 
and 42% for sonography.39 Herrero et al also found that parous women could 
subjectively estimate the weight of their fetus within 10% of actual weight just as 
accurately as a physician using abdominal palpation(62% vs. 60.9%) and in their 
study neither maternal factors such as race, age and parity, nor physician 
experience improved the fetal weight estimations.40 
 
A fourth method of estimating fetal weight  was cited by Nahum et al and validated 
using 3 databases.41,42,43. It uses parental and pregnancy-specific information such 
as maternal height, race, pregnancy weight gain, parity, fetal gender and 
gestational age to predict birth weight. This technique proved superior in predicting 
fetal macrosomia with 57% sensitivity, 90% specificity and positive and negative 
predictive values of 47% and 93% respectively.41,42 
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The medical world is innovative, constantly changing and developing. With the 
advent of new technologies, estimating fetal weight may eventually become more 
accurate than previously described. It appears that fetal weight estimates using  a 
90 second single shot spin-echo sequence MR acquisition with 8-mm thick slices 
in the axial plane at term are extremely accurate and are better than sonographic 
estimates. This may be helpful in identifying infants at risk for shoulder dystocia,  
that occurs with maternal diabetes or post term gestations as well as growth 
restricted infants,  where timing and mode of delivery are affected by fetal 
weight.44.  
 
Much debate surrounds the optimal management of a suspected macrosomic 
infant, where the role of elective caesarean section or induction of labour is 
questioned. Induction of labour appears to have little benefit to mother or baby, as 
it may result in an increased caesarean delivery rate without improving perinatal 
outcomes.45 A systematic review of current literature by Sanchez-Ramos et al 
suggests that labour should not be induced in non-diabetic pregnancies, and 
therefore, expectant management appears to be the accepted policy,45,46 i.e. await 
spontaneous labour or induce labour after 42 weeks completion.10 This rationale 
may be based on the inaccuracies of prediction of fetal macrosomia.14 
 
Caesarean delivery appears to be protective for brachial plexus injury. 1  However, 
a great number of caesarean section deliveries have to be performed to avoid a 
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single case of brachial plexus paresis resulting from a difficult shoulder delivery.10 
Rouse and Owen (1999) concluded from their study that mandating prophylactic 
caesarean delivery at a macrosomia threshold of 4000g by ultrasound in 
pregnancies not complicated by diabetes would require 2345 caesarean sections 
and 4.9 million dollars to avert a single brachial plexus injury. With a macrosomia 
threshold of 4500g, 3695 caesarean deliveries  would be need to be performed at 
a cost of  8.7 million dollars per permanent injury averted, demonstrating the poor 
performance of such ultrasound policies 1, 30 This evidence appears contrary to the 
obstetric belief that caesarean section at a greater estimated fetal weight would 
avert more fetal injury and although in modern obstetrics our management follows 
evidenced based principles, future research would be needed prior to changing 
the protocol for performing caesarean sections for large for gestational age babies, 
especially those >4500g. 
 
Studies suggest that interventions such as caesarean delivery may function more 
effectively in populations that are at increased risk for macrosomia, i.e. women 
with diabetes or those who have had prior large infants.1 The most favourable 
cost-benefit ratio for elective caesarean section in suspected macrosomic infants 
was found in diabetic women.25,30  
 
With all this information in the background, our study was undertaken with four 
primary objectives in mind: 
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1. To determine the prevalence of macrosomic babies delivered at Coronation 
(now Rahima Moosa) Hospital. 
2. To compare the maternal and neonatal outcomes between vaginally born 
macrosomic  babies versus vaginally born babies less than 4000g. 
3. To determine maternal and neonatal outcome according to mode of delivery 
of the macrosomic babies. 
4. To compare clinical variables for macrosomia noted in our study with those 
published in the literature. 
 
3 PATIENTS AND METHODS 
Our study took place at Coronation (Rahima Moosa) Hospital, Gauteng, a 
secondary level hospital and referral centre that serves a population of  
predominantly low and medium socio-economic status. The study period was from 
1 January 2005 – 30 June 2005. Permission to perform this study was obtained 
from the CEO of Coronation (Rahima Moosa) Hospital after approval was granted 
by the Human Research Ethics Committee (University of the Witwatersrand). 
 
 
THERE WERE THREE PARTS TO THIS STUDY: 
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The FIRST PART was a retrospective descriptive study. We included all the viable 
live births (≥1000g) and all the macrosomic live births, irrespective of mode of 
delivery, to calculate the prevalence of macrosomia in our study population that 
were delivered over a 6 month period, 01-01-05 to 31-06-05 at the hospital. 
 
The SECOND PART was a retrospective birth cohort, which compared the 
outcome of vaginally delivered macrosomic babies with babies weighing 2.5-
3.99kg who were also born vaginally. Maternal and fetal outcomes were 
compared in these two groups. The control patient (non-macrosomic group) was 
defined as the subsequent vaginal delivery following the macrosomic delivery in 
the maternity register, provided it fulfilled the inclusion criteria of our study. The 
control or non-macrosomic group was matched 1:1 to the macrosomic group. 
 
The THIRD PART was a retrospective analysis of the macrosomic infants only and 
compared maternal and foetal outcomes according to mode of delivery, namely 
vaginal delivery vs. elective vs. emergency caesarean section. 
 
We defined fetal macrosomia as a fetal weight ≥ 4000g, the currently accepted 
definition of the developed world .15 
Data were obtained from three sources namely, a birth register kept in the labour 
ward and theatre, maternal case files and antenatal clinic cards.  
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Data were collected and recorded on a data sheet. Clinical variables used on the 
data sheet included maternal age, maternal race, parity, gestational age, fetal sex, 
history of or presence of maternal diabetes or gestational diabetes, previous 
macrosomic baby and maternal weight gain during pregnancy. Mode of delivery 
was also noted. Maternal height measurements are not routinely performed at 
Coronation (Rahima Moosa) hospital and therefore maternal body mass index 
(BMI) was not included in our data sheet. 
 
Maternal outcomes documented included length of labour, length of second stage, 
progress on the partogram, use of augmentation, perineal trauma, postpartum 
haemorrhage, puerperal fever - defined as a temperature rise above 37.80C 
maintained over 24 hours or recurring during the period from the end of the 1st  to 
the end of the 10th day postpartum)  and puerperal sepsis - defined as a toxic 
condition caused by infection in the birth canal, occurring as a complication or 
sequel of pregnancy.  
 
The  fetal outcomes documented included fetal distress, fetal hypoxia  defined as 
deficient oxygenation of fetal blood and expressed as an apgar score <7 at five 
minutes, apgar scores, presence or absence of shoulder dystocia, any fetal 
fractures, neurological and or brachial plexus injuries, admission to intensive care 
unit and admission to the paediatric wards. Admission to neonatal intensive care 
unit (NICU) occurred in accordance to the paediatric department at Coronations 
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protocol, which includes admission for respiratory failure, carbon dioxide  
retention, a drop on arterial and venous ph, meconium aspiration, persistent 
pulmonary hypertension of the newborn and birth asphyxia (this is dependent on 
the severity of the asphyxia and the availability of NICU beds.) 
 
Macrosomic infants are routinely observed either in the neonatal ward or with their 
mothers in the ward for 24 hours and have 4 hourly analysis of serum glucose 
using the heel prick test. 
 
Postpartum haemorrhage was defined as estimated blood loss greater than 500ml 
in a normal vaginal delivery and 1000ml in a caesarean section or blood loss 
causing haemodynamic instability and or requiring blood transfusion. Maternal 
trauma was defined as follows: A first degree tear  was defined as injury to 
perineal skin only, a second degree tear as an injury to the perineum involving 
perineal muscles but not involving the anal sphincter. A third degree tear was 
defined as an injury to the perineum involving the anal sphincter complex and a 
fourth degree tear involved injury to the perineum involving the anal sphincter 
complex and anal epithelium.47 
 
Babies weighing <2.5kg, multiple pregnancies and stillbirths were excluded from 
this study. The majority of normal vaginal deliveries at Coronation hospital are 
performed by nurses/midwives and only complicated deliveries require doctors’ 
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involvement. The majority of caesarean sections performed are by the registrar on 
duty in theatre or on call. 
 
Data analysis was performed using Epi-info 6 statistical software. Descriptive 
analysis was used to meet objective 1 i.e. calculation of the prevalence of 
macrosomia in the study population. Analytic statistics were done using Chi-
squared and Fisher’s exact test for comparisons of frequencies .Student’s t-test 
and Kruskal Wallis tests were used for comparison of continuous and ordinal data 
as applicable. A p-value < 0.05 was accepted as indicating statistical significance. 
 
4 RESULTS 
4.1 PART 1: PREVALENCE 
A total of 134 macrosomic infants were identified in the study period, of which 76 
were delivered vaginally, 14 by elective caesarean section and 44 by emergency 
caesarean section. However 2 of the files of the 76 macrosomic infants delivered 
vaginally could not be found and data was hence unavailable. These two in fact 
were removed from the final analysis which therefore included 132 macrosomic 
infants, 74 of which delivered vaginally, 14 by elective caesarean section and 44 
by emergency caesarean.  During the study period, there were 5800 deliveries, of 
which 4636 delivered vaginally and 1164 by caesarean section. The incidence of 
macrosomia in the study population was 2.3% and the overall caesarean section 
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rate for all was 20%. Caesarean section for the delivery of macrosomic infants 
accounted for 5% of the total caesarean section rate. 
 
4.2  PART 2: MACROSOMIC VERSUS NON-MACROSOMIC 
INFANTS BORN VAGINALLY 
This part of the study included data of the 74 macrosomic infants delivered 
vaginally and was compared to the data of 74 non-macrosomic infants as the 
control group matched on a 1:1 ratio. 
 
The epidemiologic and obstetrics characteristics of the population are 
demonstrated in Table 1.  
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4.2.1 Table 1. Maternal demographics, obstetric and clinical variables for 
vaginally delivered macrosomic versus non-macrosomic infants. 
Variable Macrosomic (74) Non-macrosomic (74) p-value 
Maternal race 
(number) 
74 74 0.62 
- African 62 60  
- Coloured 7 10  
- Asian  2 3  
- Caucasian 3 1  
Maternal age 
(years) (±SD) 
28.1 (5.7) 27.0 (5.5) 0.24 
Parity (number) 74 74 0.96 
- 0 19 18  
- 1 25 27  
- 2 18 18  
- 3 8 8  
- 4+ 4 3  
Gestational age 
(weeks) (±SD) 
39.0 (1.3) 38.0 (1.3) <0.0001 
Gestational age 
 ≥ 41 weeks 
(number) 
8 1 0.017 
Birth weight (grams) 
(±SD) 
4145 (172) 3153 (354) <0.0001 
Male: female ratio 
(number) 
52:22 32:42 0.0009 
Partogram 
(number) 
n=60 n=52 0.012 
-Normal 49 50  
-Alert 11 1  
-Action 0 1  
Diabetes mellitus 
(number) 
0 0 N/S 
Gestational 
diabetes (number) 
0 2 N/S 
Previous big baby 
(number) 
8/62 8/48 0.58 
SD standard deviation   
N/S not significant 
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Stratifying the patients according to race, showed no significant difference 
between the macrosomic and non-macrosomic group when analysed using the chi 
square test p=0.62. 
 
Maternal age ranged from 15 years (2 patients) to 45 years (1 patient). Gestational 
age ranged from 35-43 weeks gestation. In the macrosomic group the range of 
birth weights was 4000g-5520g, with a mean weight of 4145g (±172). 
 
In 60 with macrosomic infants  and 52 mothers with non-macrosomic infants, a 
partogram was used or could be extrapolated. The results were: In the 
macrosomic group, 49/60 had a normal partogram, 11/60 crossed the alert line 
and 0/60 crossed the action line (p=0.012). 
In the non macrosomic group, 50/52 had a normal partogram, 1/52 crossed the 
alert line and 1/52 crossed the action line.  
  
No patient in either group( macrosomic vs. non macrosomic infant) was a known 
diabetic, although 2 patients in the non-macrosomic group had gestational 
diabetes. 
Eight (8) patients from each group had previously had macrosomic babies, 8/62 in 
the macrosomic group and 8/48 in the non-macrosomic group (p=0.58). This was 
not statistically significant.  
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Table 2 demonstrates the findings for fetal outcome. 
4.2.2 Table 2. Comparison of fetal outcome in the macrosomic vs. non-
macrosomic infants that were delivered vaginally. 
 
Variable Macrosomic  
(74) 
Non-macrosomic 
(74) 
p value 
Apgar score 
(number) 
   
-Apgar1   <7 3 3 N/S 
-Apgar5   <7 0 0 N/S 
-Apgar10 <7 1 0 N/S 
Shoulder dystocia 
(number) 
5 0 0.03 
Fractures(number) 0 0 - 
Neonatal ICU 
admission 
(number)  
0 0 - 
Admission to 
paediatric ward 
(number) 
9 6 0.40 
 
The incidence of fetal distress did not differ in the 2 groups with 2 non-macrosomic 
and 1 macrosomic babies being described as having fetal distress. This was 
based on clinical impression only. The incidence of hypoxia was not different 
between the two groups. 
Shoulder dystocia occurred in 5 of the 74 macrosomic and in none of the non-
macrosomic babies respectively. This was significantly different in the two groups 
(p=0.03) No babies suffered fractures at delivery, nor were there admissions to 
 26 
 
paediatric ICU. Nine of the 74 macrosomic infants and 6 of the 74 non-
macrosomic infants were admitted to the paediatric ward for observations 
(p =0.40).  
 
Data relating to labour and maternal outcomes after normal vaginal delivery are 
noted in Table 3. 
 
 27 
 
4.2.3 Table 3. Labour and maternal outcome: macrosomic vs. non-
macrosomic, vaginally delivered infants 
 
Variable Macrosomic 
(74) 
Non-
macrosomic 
(74) 
P value 
Length of labour 
(±SD) in hours 
13.7 (7.6) 
n=72 
10.9 (5.6) 
 n=73  
0.032 
Length of second 
stage (±SD) in 
minutes 
26.7 (24.5) 20.4 (16.0) 0.12 
Use of augmentation 
(number) 
16 5 0.009 
Perineal 
trauma(number) 
74 74  
 - Nil 40 55 - 
 -1st degree tear 18 9 0.010 
 -2nd degree tear 1 4 - 
 -3rd degree tear 0 0 - 
- Episiotomy(number) 15 6 0.03 
Post partum 
haemorrhage(number) 
10 2 0.016 
Puerperal fever 
(number) 
4 1 N/S 
Puerperal sepsis 
(number) 
0 0 N/S 
Birth weight  (grams) 
(±SD) 
4145 (172) 3153(354) <0.0001 
 
The length of labour in the in the macrosomic group was 13.7 hours (±7.6) and in 
the non-macrosomic group was 10.9 hours (±5.6) (p=0.032). The length of labour 
was only calculated or found in 72 of the 74 macrosomic infants and 73 of the 74 
non-macrosomic infants. The length of second stage was 26.7 minutes (±24.5) in 
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the macrosomic group vs.20.4 minutes (±16.0) in the non-macrosomic cohort 
(p=0.12). Use of augmentation was significant in the macrosomic group where 
16/74 patients received augmentation vs. 5/74 of the non-macrosomic group 
(p=0.009).  
 
When analysing the severity of perineal trauma, there was a significant difference 
in perineal damage between the macrosomic (34/74) and non-macrosomic (19/74) 
cohorts (p=0.010). When analysed according to the number of episiotomies 
performed in each group, a significant difference was found, with 15/74 
episiotomies in the macrosomic group vs. 6/74 in the non-macrosomic group 
(p=0.03). It is not policy at Coronation (Rahima Moosa) Hospital to perform routine 
episiotomies. An episiotomy is performed selectively according to the doctor or 
midwife’s clinical discretion. 
 
Post partum haemorrhage reached statistical significance with 10/74 cases in the 
macrosomic group vs. 2/74 in the non macrosomic group. None of these patients 
required blood transfusions. Puerperal fever occurred more commonly in the 
macrosomic group i.e. 4 vs. 1, although this did not reach statistical significance.  
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4.3  PART 3: MODE OF DELIVERY: COMPARISON OF 
MACROSOMIC INFANTS ACCORDING TO VAGINAL 
DELIVERY VS. ELECTIVE VS. EMERGENCY CAESAREAN 
DELIVERY. 
A separate analysis was performed comparing epidemiological factors, clinical 
variables and maternal and fetal outcomes using the 3 different modes of delivery 
for all the macrosomic fetuses’ i.e. normal vaginal delivery, elective and 
emergency caesarean section. Of the 132 macrosomic infants, 74 were delivered 
vaginally, 14 by elective caesarean and 44 by emergency caesarean section 
during the study period. Of the macrosomic babies delivered by caesarean 
section, 2 were performed for antenatally diagnosed macrosomia –suspected 
clinically and by ultrasound (the one patient was a gestational diabetic and the 
other a known insulin dependent diabetic), 2 on maternal request for sterilization in 
a multiparous patient, 2 for breech presentation, 2 for suspected cephalopelvic 
disproportion and in 5 patients who had had a previous caesarean section.  
Twelve of the emergency caesarean deliveries were for fetal distress, 4 in patients 
who had had a previous caesarean section and had not progressed appropriately 
in this labour, 23 for cephalopelvic disproportion, 3 for breech presentation in 
labour, 1 for prolonged rupture of membranes and 1 for macrosomia. 
 
Table 4 illustrates the demographic and epidemiological details for the three 
different modes of delivery study (macrosomic only) groups. 
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4.3.1 Table 4. Comparison of the demographic, epidemiological 
differences and clinical variables in the three different mode 
of delivery groups for MACROSOMIC infants. 
 
Variable Vaginal 
delivery 
(74) 
Elective 
caesarean 
(14)  
Emergency 
caesarean 
(44) 
Total 
(132) 
P 
value 
Maternal 
Race(number) 
74 14 44 132 0.167 
- African 62 9 40 111  
- Coloured 7 4 3 14  
- Asian 2 1 0 3  
- Caucasian 3 0 1 4  
Age (years) (±SD) 28.1 (5.7) 30.6 (7.7) 28.8 (5.6) 28.6 (5.9) 0.33 
Parity (number)     0.40 
- 0 19 5 19   
- 1 25 4 12   
- 2 18 3 5   
- 3 8 0 7   
- 4+ 4 2 2   
Gestational age 
(weeks) (±SD)   
39.0 (1.3) 39.1 (1.6) 38.3 (1.9) 39.1 (1.6) 0.28 
Birth weight (grams) 
(±SD) 
4145.2 
(172) 
4161.0 
(197) 
4246.0 
(272) 
4180(216) 0.079 
Male to female ratio 52:22 10:4 25:20  0.23 
Previous big baby 
(number) 
8 (n=62) 4 (n=11) 3 (n=37)  0.055 
Diabetes mellitus 
(number) 
0 1 0  0.10 
Gestational diabetes 
(number) 
0 1  0  0.10 
Partogram  (number)  n=60  n=25  0.01 
- Normal  49 - 11   
- Alert 11 - 9   
- Action 0 - 5   
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The partogram was used in 60 of the patients who had a normal vaginal delivery, 
and in only 25 of the patients who had emergency caesarean sections. In the 
normal vaginal delivery group, 49/60 had normal partograms, 11/60 had crossed 
the alert line and none crossed the action line. In the emergency caesarean 
section deliveries, 11/25 had normal partograms, 9/25 crossed the alert line and 
5/25 crossed the action line (p=0.01).  
 
There was only one diabetic and one gestational diabetic in this section of our 
study group, both of whom were delivered by elective caesarean section. 
 
A significant number of the babies delivered by emergency caesarean section had 
foetal distress (p=0.0001). See Table 5 which shows outcome measures of 
neonates according to mode of delivery.  
 
The one minute apgar score shows that a total of 3 neonates born by normal 
vaginal delivery had apgar scores of <7 vs. 0 in the elective caesarean delivery 
group and 1 for the emergency caesarean group. This was not significant. 
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Data comparing differences in fetal outcome for the three groups is illustrated in 
Table 5. 
4.3.2 Table 5. Comparison of fetal outcome in the macrosomic group of 
neonates stratified according to mode of delivery. 
 
Variable Vaginal 
delivery 
Elective 
caesarean 
Emergency 
caesarean 
p value 
Fetal 
distress(number) 
1 0 13 <0.0001 
Hypoxia(number) 2 0 4 N/S 
Fractures(number) 0 0 0 - 
Admission to ICU 
(number) 
0 0 0 - 
Admission to 
paediatric ward 
(number) 
9 0 2 0.17 
Apgar score 
(number) 
    
- Apgar1    <7 3 0 1 0.16 
- Apgar5    <7 0 0 0 - 
- Apgar10  <7 1 0 0 N/S 
 
Data comparing differences in labour and maternal outcomes for the three groups 
is illustrated in Table 6. 
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4.3.3 Table 6. Outcome of mothers with macrosomic infants stratified 
according to mode of delivery 
 
Variable Vaginal 
delivery 
Elective 
caesarean 
Emergency 
caesarean 
p value 
Use of 
augmentation 
(number) 
16 0 12 0.48 
Post partum 
haemorrhage 
(number) 
10 0 4  
Puerperal 
fever 
(number) 
4 5 14 0.0001 
Puerperal 
sepsis 
(number) 
0 0 1 N/S 
 
Augmentation was given to 21.6% of the patients in the vaginal delivery group vs. 
27.3% of the emergency caesarean section group which was not significantly 
different. 
 
Ten of the 74 patients in the vaginal delivery group, none of the elective caesarean 
deliveries and 4 of the 44 patients having emergency caesarean deliveries had 
post partum haemorrhage. A significant number of patients who had elective and 
emergency caesarean section developed puerperal fever, 36% and 32% 
respectively vs. 5% of vaginal delivery, (p=0.0001) and 1 patient from the 
emergency caesarean group suffered from puerperal sepsis, which was not 
significant. 
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5 DISCUSSION 
Interestingly, the incidence of macrosomia in our study group was only 2.3%. As 
described earlier, the incidence of macrosomia in different countries is extremely 
variable, and the lower incidence in our study is somewhat similar to that 
expressed by others, namely 3.43%at the Umtata Hospital in the Eastern Cape15 , 
3.4% at the Kuopio University Hospital, Finland22 and 2.3% at the Chiawelo Clinic  
Soweto16 respectively.15,16,22  The low incidence in our study, and those mentioned 
above are in sharp contrast to the greater incidence seen in the United States, 
where macrosomia complicates more than 10% of all pregnancies12,48 and in 
Denmark and the Republic of Croatia where it has surprisingly been shown to 
be ≥ 20%.14  As was theorized earlier the possible explanation for this may be the 
alarming increase in obesity in the affluent countries. 19 In Scotland alone the 
number of women with a body mass index above 30(clinically obese) has doubled 
with 9.4% defined as obese in 1990 vs. 18.9% in 2002/2004.20. This has been 
followed by a rise in the prevalence of type 2 diabetes in these developed 
countries. In Germany the prevalence of overweight and obesity has increased 
significantly from 1991-1998 and the prevalence of type 2 diabetes increased 
20-fold over the last 50 years, resulting in 4.6% of the population now being 
afflicted.19. 
 
Several risk factors for the development of fetal macrosomia have been identified, 
namely advancing maternal age, ethnicity (Caucasian)17 , high parity, height or 
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stature, weight gain during pregnancy, maternal obesity (BMI>30)18, previous 
history of macrosomic infant, impaired glucose tolerance, maternal diabetes, 
prolonged pregnancy (>40 weeks gestation)17, non smokers and male fetus. 
Unfortunately, maternal weight, weight gain during the pregnancy and height are 
not recorded on the antenatal clinic cards at Coronation (Rahima Moosa) Hospital 
and therefore this data was not available for analysis.  
 
In our study, the mean maternal age in the macrosomic group was 28.1 years 
(±5.7) versus 27.0 years (±5.5) in the non-macrosomic group. This difference was 
not found to be significant, although there was a trend towards mothers with 
macrosomic infants having a more advanced maternal age, i.e. a mean of 28.6 
years (±5.9). Of interest to note is that the mean maternal age in the elective 
caesarean group was 30.6 years (±7.7). These findings are similar to those of 
larger studies that suggest that older women (in their third decade or more) are at 
an increased risk of having a macrosomic infant. 11,13,15,48 Stotland el al (2004)  
found that a maternal age of 30-40 years was associated with macrosomia, 11 and 
Jolly et al (2003) found fetal macrosomia was more likely to occur in women who 
were >40 years of age (Odds ratio 1.22, Confidence interval 1.11, 1.35). 13 
 
With regards to maternal race/ ethnicity, analysis of our data revealed no statistical 
significance (p=0.62), with similar values for each race in both the study and 
control cohorts and when comparing mode of delivery. Incidentally there was only 
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a small number of Caucasian patients in our study, 5 in total. This may possibly be 
the reason for the reduced incidence of macrosomia in our study population as 
seen in other studies 15,16 as Caucasian race appears to be a significant risk factor 
for macrosomia in several studies.11,13,48. The number of Caucasian patients 
delivering at Coronation (Rahima Moosa) Hospital is small compared to non-
Caucasian patients. All patients at Coronation (Rahima Moosa) are screened for 
gestational diabetes if their risk profile according to their by history or antenatal 
findings deems it necessary, i.e. previous gestational diabetes, family history of 
diabetes, previous macrosomic infant, previous unexplained intrauterine fetal 
death or congenital abnormality, maternal weight  >100kg and persistent 
glycosuria. Routine screening is not undertaken. 
 
Increased maternal parity appears to be associated with fetal macrosomia.49 This 
sentiment was echoed by Jolly et al (2003) in their study, where women with a 
parity of >4 were found to be more likely to deliver macrosomic infants (OR 2.20, 
CI 2.02, 2.40).13 Mulik et al (2003) in their study looked at the outcome of 
macrosomic fetuses in a low risk primigravid population. It was interesting to note 
that the incidence of macrosomia in their study population was 9 %.48  In our study, 
parity was not a significant factor when considering the macrosomic vs. non- 
macrosomic babies (p=0.96) or  when considering mode   of delivery  of the 
macrosomic infants (p=0.40).  A cohort study of  146 526 mother-infant pairs by 
Stotland et al (2004) concluded that multiparity was a predictor of macrosomia.11 
We can not draw the same conclusion from our study. A total of 15 patients from 
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the macrosomic group had previously had macrosomic infants and 8/48 from the 
non-macrosomic group had previously had macrosomic infants, although this 
difference was not significant (p=0.58). Although not found in our study, prior 
studies have shown that previous history of a macrosomic birth was an 
independent risk factor of fetal macrosomia.15,22 
 
Gestational diabetes and maternal diabetes appeared not to be common findings 
in our study population (present in only 2 patients in the macrosomic group 
elective caesarean group and 2 in the non-macrosomic group). This is in contrast 
to the literature, which strongly links gestational diabetes 15,50 and maternal 
diabetes 11 to macrosomia.13,22 In fact, Zamorski et al (2001) felt that the strongest 
risk factor for macrosomia is maternal diabetes, which results in a twofold increase 
in the incidence of macrosomia.12 Daponte et al in their review of management in a 
diabetic pregnant patient found that almost one third of babies born to a diabetic 
mother was macrosomic. 51 Interestingly almost double the number of macrosomic 
babies occurred in moderately controlled patients as compared to well or strictly 
controlled patients. 51 Adams et al (1998) suggest that unrecognized gestational 
diabetes increases the risk of large for gestational infants, macrosomia, shoulder 
dystocia and birth trauma, independent of maternal obesity and other confounding 
variables.52 Unrecognized gestational diabetes is a possible reason for the 
reduced incidence of impaired glucose tolerance in our study population, whilst 
ethnicity could be another. In our study we found that both of the diabetic patients 
in the macrosomic group – one in a mother who had gestational diabetes and the 
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other a known insulin dependent diabetic were delivered electively by caesarean 
section after discovery of macrosomic features on ultrasound. 
 
Prolonged pregnancy (gestational age >41 weeks) 11 and postdatism (>42 weeks 
of gestation) 15, 22 have all been identified as independent risk factors for 
macrosomia. The findings in our study are congruent with those of previous 
reviews with the study group having a significantly more advanced gestational age 
39.0 weeks (±1.3) vs. 38.0 weeks (±1.3) than the control group (p<0.0001).The 
average gestational age of all the macrosomic infants was 39.1 weeks (±1.6). 
Eight (8) times the number of infants in the macrosomic group had a gestational of 
≥ 41 weeks when compared to the non macrosomic group i.e. 11% vs.1.3%. 
p=0.017. 
 
The preponderance of male infants in our study is in agreement with findings from 
other studies.11,15,22 In our study, over 70% of the macrosomic infants were male 
vs.43% in the control group (p=0.0009). These findings follow through into the 
macrosomic, mode of delivery part of the study where 66% of these infants were 
male. It is evident from the literature that there are a multitude of risk factors 
associated with the possible development of macrosomia. Yet, Zamorski et al 
(2001) who analyzed this concept, found that only 32% of infants developed 
macrosomia when two or more risk factors were present, 34% of macrosomic 
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babies were born to mothers without any risk factors, and 38% of pregnant women 
have at least one risk factor.12 
 
6 MATERNAL OUTCOMES 
Macrosomia has been associated with several adverse maternal outcomes, 
namely; increased risk for delivery by caesarean section, 12 increased perineal 
tears and trauma, 11 obstructed labour, post partum haemorrhage, prolonged 
labour, increased use of augmentation 11,13,48  risk of instrumental vaginal delivery, 
13 prolonged hospital stay and chorioamnionitis.11 
 
In the normal vaginal delivery component of our study, our findings concurred with 
the literature in terms of  the increased incidence of post partum haemorrhage, 
(10 vs. 2),  increased incidence of third degree tears and severe perineal 
trauma,(15 vs. 6) and puerperal fever (4 v 1), amongst the mothers that delivered 
macrosomic babies versus those mothers that delivered non-macrosomic babies, 
all of which were statistically significant. Also of note was the increased need for 
augmentation in the macrosomic group (16 v 5) which suggests an underlying 
dysfunctional labour (p=0.009). This may also explain the prolonged length of 
labour in the macrosomic group (13.7 hours (±7.6) vs. 10.9 hours (±5.6) (p=0.032) 
and increased length of second stage. (26.7 minutes (±24.5) vs. 20.4 minutes 
(±16.0) (p=0.12).   
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Xenakis et al (1997) discovered that any oxytocin requirement in labour is 
associated with a greater increase in caesarean section rate for macrosomic than 
for non macrosomic pregnancies.53 This is confirmed in our study by the fact that 
12/44 (27%) of the macrosomic infants delivered by emergency caesarean section 
had received augmentation before proceeding to caesarean section. It may be that 
cephalopelvic or feto-pelvic disproportion with ineffective uterine action due to the 
increased uterine volume may have been the underlying cause for the prolonged 
or dysfunctional labour requiring augmentation. These deductions are implied by 
the fact that 20% of the patients requiring delivery by emergency caesarean 
section had crossed the action lines on the partogram. The majority of deliveries 
by emergency caesarean, 23/44 (52%) were performed for cephalopelvic 
disproportion, (which included deliveries by emergency caesarean section for poor 
or no progress), these findings concur with those in the literature.  
 
Higher rates of serious intra- and postoperative maternal complications have been 
reported for delivery by caesarean section as compared to vaginal delivery.25,54 
Puerperal fever, sepsis and post partum haemorrhage are some of the maternal 
complications cited in the literature.10, 55 In our study 10 (13.5%) of the women who 
had normal vaginal deliveries suffered post partum haemorrhage compared to 4 
(9%) in the emergency caesarean section group and none in the elective 
caesarean section group. Conway et al (2002) found more complications in 
women delivering macrosomic infants vaginally than in women delivering 
macrosomic infants by caesarean section without labour.3, 54 Our findings concur 
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with their studies. Results from our study differ slightly from the literary findings in 
terms of poorer outcomes with caesarean section, when comparing vaginal 
deliveries with emergency caesarean section. However the better outcome of 
elective vs. emergency caesarean section, in terms of post partum haemorrhage, 
supports literary findings that the complication rates of unplanned operations are 
higher than planned operations. 55  
 
Regarding other complications such as puerperal fever and sepsis, our findings 
concurred with the literature as 5 (36%) patients in the elective caesarean section 
group, 14 (32%) in the emergency caesarean section group and only 4 (5%) in the 
normal vaginal delivery group experienced puerperal fever (p=0.0001). The 
increased incidence among women who had an elective caesarean section may 
be misleading however, due to the small number of patients in this group. The 
increased incidence of puerperal fever among women who had an emergency 
caesarean vs. normal vaginal delivery group however, was statistically significant. 
One patient from the emergency caesarean section group suffered from puerperal 
sepsis. 
 
7 FETAL OUTCOMES 
Low apgar scores, 13 fetal distress, fetal hypoxia, 12 paediatric ICU admission, 56 
admission to paediatric wards, 13 shoulder dystocia, 12, 57 brachial plexus and 
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neurological injuries as well as clavicular and humeral fractures are among the 
fetal complications and adverse fetal outcomes associated with fetal macrosomia. 
25, 48 Herbst (2005) found that neonatal fractures of the clavicle and/or humerus 
occur in 1-2% of vaginal deliveries, with an increased incidence that is associated 
with shoulder dystocia.46 Of interest, in our study, there were no clavicular or 
humeral fractures.  
 
In the macrosomic versus non macrosomic part of our study, each group had 
equal numbers of babies with an apgar score <7 at one minute i.e. 3 and the 
macrosomic group had 1 baby with an Apgar score <7 at 10 minutes. These 
findings were not statistically significant.  
Haram et al (2002) found that Apgar scores were often lower in macrosomic 
babies delivered by caesarean section compared with vaginal deliveries.10 Our 
findings, with regards to apgar scores, did not confirm this, nor did they reach 
statistical significance, with 4 babies from the normal vaginal delivery group and 1 
from the emergency caesarean section group having apgar score of <7 at one, five 
or ten minutes (p=0.16). 
 
Fortunately none of the neonates in our study required a neonatal intensive care 
unit (NICU) admission. Gillean et al (2005) in a study analysing admission of 
macrosomic infants to neonatal intensive care unit identified risk factors for 
prolonged NICU stay. Among other factors, they found that prolonged labour per 
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se did not put the fetus at risk, but rather the consequences of prolonged labour 
such as fever, caesarean section delivery and low apgar score.56 These findings 
indicate that macrosomic infants warrant increased attention in labour.56,59 Of 
interest was that diabetes, caesarean section delivery and lower gestational age 
doubled the risk of admission.56 Their findings are similar to those of Nasser et al 
(2003) who found longer nursery stays among neonates born by caesarean 
section. 56,60 Haram et al (2002), noted that there is a lower reported incidence of 
the use of neonatal intensive care after vaginal delivery (2.1%) compared with 
caesarean section (6.0%).10 
 
In our study, although not statistically significant, 9 macrosomic infants vs. 6 non 
macrosomic infants required admission to the paediatric ward for observation 
(p=0.40). Macrosomic infants delivered vaginally were three times more likely to 
require observation in the paediatric ward than infants born by elective caesarean 
section (12% vs. 4.5%). Differences in the findings of fetal distress and hypoxia in 
the macrosomic and non-macrosomic group did not reach statistical significance; 
similar results were found in the mode of delivery group regarding hypoxia. 
However, a significant number (29.5%) of babies in the emergency caesarean 
delivery were reported to have fetal distress (p<0.0001). 
Shoulder dystocia is marked by difficulty in delivery of the anterior fetal shoulder 
after the appearance of the fetal head on the maternal perineum. Acker et al 
(1985) first described the details of this association.1 They found the incidence of 
shoulder dystocia in their population to be 0.2% in infants weighing 2500-2999g, 
 44 
 
0.6% for 3000-3499g, 2.2% for 3500-3999g, 10% for 4000-4499g and 22.6% for 
infants weighing more than 4500g.1 The shoulder dystocia rate among 
macrosomic infants born vaginally is significantly higher than among appropriately 
grown infants, and the rate among diabetic women is higher than among non-
diabetics. Langer et al (2000) found a shoulder dystocia rate of 0.3% when birth 
weight was <4000g and 4.9% when ≥ 4000g. Non diabetic women had an overall 
shoulder dystocia rate of 0.5% compared to 3.2% in diabetic women.25,54 In our 
study none of the patients from the non-macrosomic group (<4000g) had shoulder 
dystocia versus 6.8% or 5/74 from the macrosomic group and none of these 
patients were diabetic. None of the patients delivered by caesarean section 
suffered shoulder dystocia, or its complications. “Increased birth weight is a well 
described risk for brachial plexus injury. As expected, the incidence of brachial 
plexus injury increases with increasing birth weight. Among infants born to non-
diabetic mothers, the incidence was 0.5 out of 1000 live births among infants 
weighing less than 4000g compared with 26.8 out of 1000 live births for infants 
weighing more than 5000g.”1 Fortunately none of the neonates in either part of our 
study suffered from brachial plexus injuries. Ecker et al (2004) found that the 
presence of pregestational or gestational diabetes was associated with increased 
risk for brachial plexus injury (odds ratio=3.19).1 The low incidence of 
pregestational or gestational diabetes in our study population may provide a partial 
explanation for the absence of brachial plexus injuries in our study.   
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The fact that the adverse maternal and fetal outcomes in the macrosomic and 
mode of delivery component of our study differ so slightly and that macrosomic 
infants born vaginally appear to do well, with few adverse sequelae, leads one to 
deduce that elective caesarean section for suspected macrosomia may result in a 
high number of unnecessary surgical procedures. Early induction of labour to limit 
fetal growth, may result in a substantial increase in the caesarean section rate 
because of failed inductions.12 Expectant management of the suspected 
macrosomic infant appears appropriate.45,46 
The ACOG practise bulletin no. 22 provides similar recommendations:26 
1. Based on good and consistent scientific evidence: 
a. The diagnosis of fetal macrosomia is imprecise and the accuracy of 
estimated fetal weight using ultrasound biometry is no better than 
that obtained with clinical palpation. 
2. Based on limited or inconsistent scientific evidence: 
a. Suspected fetal macrosomia is not an indication for induction of 
labour, because induction does not improve maternal or fetal 
outcome. 
b. Labour and vaginal delivery are not contraindicated for women with 
estimated fetal weights up to 5000g in the absence of maternal 
diabetes. 
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c. With an estimated fetal weight of more than 4500g, a prolonged 
second stage of labour or arrest of descent in the second stage is an 
indication for caesarean delivery. 
3. Recommendations based primarily on consensus and expert opinion: 
a. Although the diagnosis of fetal macrosomia is imprecise, prophylactic 
caesarean delivery may be considered for suspected fetal 
macrosomia with estimated fetal weights of more than 5000g in 
pregnant women without diabetes and more than 4500g in pregnant 
women with diabetes. 
b. Suspected fetal macrosomia is not a contraindication to attempted 
vaginal birth after a previous caesarean delivery.26 
8 LIMITATIONS 
There are a number of limitations to our analysis and data collection. Several of 
the maternal files were incomplete. The information we obtained from the maternal 
antenatal clinic cards, maternal files and maternity register did not include 
maternal weight, height or maternal pregnancy weight gain, which, in the literature, 
have been shown to be important risk factors for fetal macrosomia. Our study was 
also limited by the fact that we do not have long term follow up of both the mothers 
and their macrosomic infants, to assess the long term consequences associated 
with macrosomia. Another limitation is the small sample size; a larger study 
population could provide more substantial analyses. 
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9 RECOMMENDATIONS 
From the published literature and data obtained from our study, the following 
concepts appear most significant: 
 
During the antenatal period, a high index of suspicion is vital and careful follow up 
at an antenatal clinic is recommended. Risk factors or co-variables may be used 
as a guide, along with clinical examination and available technology such as 
ultrasound. As a previous macrosomic baby is a strong predictor of a future 
macrosomic baby, a detailed obstetric history should be obtained. 
Having said this however, it is a well accepted fact that fetal macrosomia is 
extremely difficult to accurately diagnose predelivery. Nevertheless risk factors 
should be born in mind when assessing any pregnant woman intrapartum. 
Assessment may include clinical estimation of fetal weight and  sonographic 
estimation. 
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Even though this was a small study, and there were only 14 patients that were 
delivered by elective caesarean section, with respect to the appropriate mode of 
delivery in the case of fetal macrosomia, expectant management of the mother 
with a suspected macrosomic baby offers an option that is apparently safe, 
acceptable and comparable to elective caesarean section. 
 
Women in labour require meticulous monitoring with impeccable use of the 
partogram. Good progress in labour for a suspected macrosomic infant is a 
reassuring sign. Slow progress of labour, use of augmentation and prolonged 
second stage should alert the attending physician to the possibility of fetal 
macrosomia. 
 
As shoulder dystocia is one of the most feared complications of macrosomia, and 
it is an obstetric emergency, all staff working in labour ward should be adequately 
trained in the management of this emergency. Regular refresher courses and drills 
would benefit all in the long run. 
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More research is needed on the relationship between maternal weight, height, 
maternal pregnancy weight gain, nutrition, obesity, smoking and the short and long 
term maternal morbidities associated with fetal macrosomia from a South African 
perspective. Cost effective management of a suspected macrosomic especially in 
the developing world may provide some useful management protocols. 
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